SavedAdd your journal

Journals / İstanbul Tıp Fakültesi Dergisi / 2026 / Cilt: 82 Sayı: 1

FRAILTY AND CANCER SCREENING RATES IN OLDER ADULTS

YAŞLILARDA KIRILGANLIK VE KANSER TARANMA ORANLARI

Birkan İlhan(GAZİANTEP DR. ERSİN ARSLAN EĞİTİM VE ARAŞTIRMA HASTANESİ)0000-0001-6039-5866
Oğuz Kağan Bakkaloğlu(GAZİANTEP DR. ERSİN ARSLAN EĞİTİM VE ARAŞTIRMA HASTANESİ)0000-0001-8661-5791
Pages
24–28
Publication Date
2019-03-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this study was to examine the patterns of colorectal, breast, prostate, and lung cancer screening in geriatric outpatients with different frailty statuses.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: It has been suggested that the decision of when to implement cancer screening should be based on the frailty status or life expectancy in older adults.
📊
Key Findings & Data:There is a limited number of studies reporting cancer screening prevalence in older adults.
💡
Conclusion & Impact:The aim of this study was to examine the patterns of colorectal, breast, prostate, and lung cancer screening in geriatric outpatients with different frailty statuses.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:yaşlılık · kanser · kırılganlık

Abstract

Objective: It has been suggested that the decision of when to implement cancer screening should be based on the frailty status or life expectancy in older adults. There is a limited number of studies reporting cancer screening prevalence in older adults. The aim of this study was to examine the patterns of colorectal, breast, prostate, and lung cancer screening in geriatric outpatients with different frailty statuses.

Özet

Amaç: Son zamanlarda yaşlılarda kanser taramalarına kişinin kırılganlık düzeyi veya beklenen yaşam süresine göre karar verilmesi önerilmektedir. Yaşlılardaki kanser tarama oranları ile ilgili veriler kısıtlıdır. Bu çalışmada bir geriatri polikliniğine başvuran yaşlılarda kırılganlık durumları ile birlikte kolon, meme, prostat ve akciğer kanser taraması oranlarının bildirilmesi amaçlanmıştır.

🔖

Cite This Article

İlhan, B., Bakkaloğlu, O. K. (2019). FRAILTY AND CANCER SCREENING RATES IN OLDER ADULTS. İstanbul Tıp Fakültesi Dergisi, Cilt: 82 Sayı: 1, 24–28. https://ajindex.com/articles/1113717

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. İstatistiklerle Yaşlılar 2017. TÜİK Haber Bülteni 2018:27595. Available from http://www.tuik.gov.tr/PreHaberBultenleri.do?id=24644
  2. Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique. 2008;56(3):159-75.
  3. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al. SEER cancer statistics review 1975–2014: Introduction. National Cancer Institute. Available from https://seer.cancer.gov/archive/csr/1975_2014/results_merged/sect_01_overview.pdf
  4. Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993;341(8851):973-8. Erratum in: Lancet 1993 Nov 27;342(8883):1372.
  5. Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, et al., Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA 2015;314(15):1599-614.
  6. Özkan S, Keskinkılıç B, Gültekin M, Karaca A.S, Öztürk C, Boztaş G et al. editors. Meme Kanseri Taramaları; Ulusal Kanser kontrol Planı 2013-2018. T.C. Sağlık Bakanlığı, Türkiye Halk Sağlığı Kurumu; 2014.
  7. Breast Cancer Recommendation Statement From the U.S. Preventive Services Task Force. Ann Intern Med 2016;164(6):448.
  8. Horner M, Ries L, Krapcho M, Neyman N, Aminou R, Howlader N, et al. SEER cancer statistics review 1975–2006: Introduction. National Cancer Institute. Available from https://seer.cancer.gov/archive/csr/1975_2006/results_merged/sect_01_overview.pdf.
  9. Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü “Birinci Basamak Sağlık Hizmetlerinde Çalışan Hekimler için Yaşlı Sağlığı Tanı ve Tedavi Rehberi 2010”, 78:(37-46).
  10. Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2018;319(18):1901-13.
  11. Prostat kanseri klinik protokolü, Tarama, Türk Üroloji Derneği ve Sağlık Teknolojisi Değerlendirme Daire Başkanlığı, TC Sağlık Bakanlığı Sağlık Araştırmaları Genel Müdürlüğü, 2017:(6). Available from http://hta.gov.tr/pdf/prostat_ca_20_09_1.pdf
  12. Akciğer Kanseri Çalıştayı Sonuç Raporu; T.C. Sağlık Bakanlığı, Türkiye Halk Sağlığı Kurumu. 2016:(13-21). Available from https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/yayinlar/raporlar/Akciger_Kanseri_Calistay_Raporu28042016.pdf
  13. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people.Lancet 2013;381(9868):752-62.
  14. Eckstrom E, Feeny DH, Walter LC, Perdue LA, Whitlock EP. Individualizing cancer screening in older adults: a narrative review and framework for future research. J Gen Intern Med 2013;28(2):292-8.
  15. Kotwal AA, Schonberg MA. Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening. Cancer J 2017;23(4):246-53.
  16. Walter LC, Lewis CL, Barton MB. Screening for colorectal, breast, and cervical cancer in the elderly: A review of the evidence. Am J Med 2005;118(10):1078-86.
  17. Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 2012;16(7):601-8.
  18. Royce TJ, Hendrix LH, Stokes WA, Allen IM, Chen RC. Cancer screening rates in individuals with different life expectancies. JAMA Intern Med 2014;174(10):1558-65.
  19. Torke AM, Schwartz PH, Holtz LR, Montz K, Sachs GA. Older adults and forgoing cancer screening: “I think it would be strange”. JAMA Intern Med 2013;173(7):526-31.